Apimeds Pharmaceuticals Us, Stock Market Value
| APUS Stock | 1.73 0.05 2.98% |
| Symbol | Apimeds |
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apimeds Pharmaceuticals. If investors know Apimeds will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apimeds Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Apimeds Pharmaceuticals is measured differently than its book value, which is the value of Apimeds that is recorded on the company's balance sheet. Investors also form their own opinion of Apimeds Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apimeds Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apimeds Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apimeds Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apimeds Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apimeds Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apimeds Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Apimeds Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Apimeds Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Apimeds Pharmaceuticals.
| 01/04/2024 |
| 12/24/2025 |
If you would invest 0.00 in Apimeds Pharmaceuticals on January 4, 2024 and sell it all today you would earn a total of 0.00 from holding Apimeds Pharmaceuticals US, or generate 0.0% return on investment in Apimeds Pharmaceuticals over 720 days. Apimeds Pharmaceuticals is related to or competes with Talphera, MIRA Pharmaceuticals,, Scynexis, Milestone Scientific, India Globalization, Precision Optics,, and Q32 Bio. More
Apimeds Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Apimeds Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Apimeds Pharmaceuticals US, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.38 | |||
| Information Ratio | 0.0333 | |||
| Maximum Drawdown | 53.45 | |||
| Value At Risk | (14.12) | |||
| Potential Upside | 15.05 |
Apimeds Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apimeds Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Apimeds Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Apimeds Pharmaceuticals historical prices to predict the future Apimeds Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0377 | |||
| Jensen Alpha | 0.2864 | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.0373 | |||
| Treynor Ratio | 0.2563 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Apimeds Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Apimeds Pharmaceuticals Backtested Returns
Apimeds Pharmaceuticals appears to be abnormally volatile, given 3 months investment horizon. Apimeds Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0406, which signifies that the company had a 0.0406 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Apimeds Pharmaceuticals US,, which you can use to evaluate the volatility of the firm. Please makes use of Apimeds Pharmaceuticals' Mean Deviation of 6.44, risk adjusted performance of 0.0377, and Downside Deviation of 8.38 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Apimeds Pharmaceuticals holds a performance score of 3. The firm shows a Beta (market volatility) of 1.45, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Apimeds Pharmaceuticals will likely underperform. Please check Apimeds Pharmaceuticals' sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Apimeds Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Apimeds Pharmaceuticals US, has no correlation between past and present. Overlapping area represents the amount of predictability between Apimeds Pharmaceuticals time series from 4th of January 2024 to 29th of December 2024 and 29th of December 2024 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Apimeds Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Apimeds Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Apimeds Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Apimeds Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Apimeds Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Apimeds Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Apimeds Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Apimeds Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Apimeds Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Apimeds Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Apimeds Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Apimeds Pharmaceuticals Lagged Returns
When evaluating Apimeds Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Apimeds Pharmaceuticals stock have on its future price. Apimeds Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Apimeds Pharmaceuticals autocorrelation shows the relationship between Apimeds Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Apimeds Pharmaceuticals US,.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.